CARL
Price
$18.60Alerts
Change
+$3.89 (+26.44%)
Updated
Nov 11 closing price
Capitalization
396.44M
Intraday BUY SELL Signals
PRVA
Price
$24.04Alerts
Change
-$0.33 (-1.35%)
Updated
Nov 11 closing price
Capitalization
3.12B
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CARL vs PRVA

CARL vs PRVA Comparison Chart in %
View a ticker or compare two or three
VS
CARL vs. PRVA commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARL is a Hold and PRVA is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CARL with price predictions
Nov 10, 2026

CARL saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for CARL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 17 similar instances where the indicator exited the overbought zone. In 16 of the 17 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CARL as a result. In 23 of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

CARL moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CARL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

CARL broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CARL entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CARL just turned positive on October 22, 2026. Looking at past instances where CARL's MACD turned positive, the stock continued to rise in 9 of 11 cases over the following month. The odds of a continued upward trend are 82%.

The 10-day moving average for CARL crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +6.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where CARL advanced for three days, in 59 of 72 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.706) is normal, around the industry mean (4.477). P/E Ratio (-6.214) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (6.596) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CARL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CARL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
a Summary for PRVA with price predictions
Nov 10, 2026

PRVA in upward trend: price rose above 50-day moving average on October 12, 2026

PRVA moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend. In 37 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 05, 2026. You may want to consider a long position or call options on PRVA as a result. In 58 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.

The Moving Average Convergence Divergence (MACD) for PRVA just turned positive on November 05, 2026. Looking at past instances where PRVA's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.

The 10-day moving average for PRVA crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.

Following a +2.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRVA advanced for three days, in 196 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

The Aroon Indicator entered an Uptrend today. In 139 of 211 cases where PRVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

PRVA broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. PRVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.987) is normal, around the industry mean (4.477). PRVA's P/E Ratio (106.174) is considerably higher than the industry average of (13.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.127) is also within normal values, averaging (6.065).

The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock better than average.

TECHNICAL ANALYSIS
Technical Analysis
CARLPRVA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 10 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
66%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CARL: $14.71 vs. PRVA: $24.37)
Brand notoriety: CARL and PRVA are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: CARL: 118% vs. PRVA: 76%
Market capitalization -- CARL: $396.44M vs. PRVA: $3.12B
CARL [@Services to the Health Industry] is valued at $396.44M. PRVA’s [@Services to the Health Industry] market capitalization is $3.12B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.18B. The average market capitalization across the [@Services to the Health Industry] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARL’s FA Score shows that 1 FA rating(s) are green while PRVA’s FA Score has 0 green FA rating(s).

  • CARL’s FA Score: 1 green, 4 red.
  • PRVA’s FA Score: 0 green, 5 red.
According to our system of comparison, CARL is a better buy in the long-term than PRVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARL’s TA Score shows that 3 TA indicator(s) are bullish while PRVA’s TA Score has 6 bullish TA indicator(s).

  • CARL’s TA Score: 3 bullish, 6 bearish.
  • PRVA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRVA is a better buy in the short-term than CARL.

Price Growth

CARL (@Services to the Health Industry) experienced а +2.15% price change this week, while PRVA (@Services to the Health Industry) price change was +13.51% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.67%. For the same industry, the average monthly price growth was +2.59%, and the average quarterly price growth was +28.54%.

Reported Earning Dates

PRVA is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Services to the Health Industry (+0.67% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
Interact to see
Advertisement

CARL and

Correlation & Price change

A.I.dvisor tells us that CARL and TEM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CARL and TEM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARL
1D Price
Change %
CARL100%
-8.35%
TEM - CARL
31%
Poorly correlated
-4.62%
TDOC - CARL
29%
Poorly correlated
-0.45%
PRVA - CARL
27%
Poorly correlated
-0.69%
WEAV - CARL
26%
Poorly correlated
N/A
HQY - CARL
24%
Poorly correlated
+1.40%
More

PRVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRVA has been loosely correlated with RIOT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRVA jumps, then RIOT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRVA
1D Price
Change %
PRVA100%
-0.69%
RIOT - PRVA
46%
Loosely correlated
+2.38%
EVCM - PRVA
45%
Loosely correlated
-13.30%
EVTC - PRVA
45%
Loosely correlated
-0.87%
SPT - PRVA
45%
Loosely correlated
+0.18%
QLYS - PRVA
45%
Loosely correlated
-13.51%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BAR.X0.217304-0.000705
-0.32%
FC Barcelona Fan Token cryptocurrency
GAS.X1.048885-0.005772
-0.55%
Gas cryptocurrency
JST.X0.143914-0.000956
-0.66%
JUST cryptocurrency
ILV.X2.745951-0.018692
-0.68%
Illuvium cryptocurrency
PERL.X0.000119-0.000020
-14.57%
PERL.eco cryptocurrency